US Patent Issued to BEIJING BAISHIHEKANG PHARMACEUTICAL TECHNOLOGY (BSJPHARMA) on Sept. 30 for "Microrna and uses thereof in prevention and/or treatment of fibroplasia medical sign and/or syndrome" (Chinese Inventors)

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,427,164, issued on Sept. 30, was assigned to BEIJING BAISHIHEKANG PHARMACEUTICAL TECHNOLOGY (BSJPHARMA) Co. LTD (Beijing).

"Microrna and uses thereof in prevention and/or treatment of fibroplasia medical sign and/or syndrome" was invented by Chengyu Jiang (Beijing), Jianchao Du (Beijing), Zhu Liang (Beijing), Jiantao Xu (Beijing) and Yan Zhao (Beijing).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided are microRNA from a rhodiola root and uses thereof in the prevention and/or the treatment of a fibroplasia medical sign and/or syndrome."

The patent was filed on Sept. 29, 2022, under Application No. 17/936,820.

*For further information, including ...